BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 373911)

  • 1. Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology.
    Lister TA; Cullen MH; Brearley RB; Beard ME; Stansfeld AG; Whitehouse JM; Wrigley PF; Ford JM; Malpas JS; Crowther D
    Cancer Chemother Pharmacol; 1978; 1(2):107-12. PubMed ID: 373911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of disseminated non-Hodgkin's lymphoma of unfavourable histology.
    Gallagher CJ; Copplestone A; Meikle JD; Lister TA
    Cancer Chemother Pharmacol; 1982; 8(2):237-41. PubMed ID: 7105385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy for acute lymphoblastic leukaemia in adults.
    Lister TA; Whitehouse JM; Beard ME; Brearley RL; Wrigley PF; Oliver RT; Freeman JE; Woodruff RK; Malpas JS; Paxton AM; Crowther D
    Br Med J; 1978 Jan; 1(6107):199-203. PubMed ID: 271516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
    Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
    Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
    Case DC
    Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
    Yong W; Zheng W; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of B-cell non-Hodgkin's malignant lymphomas of childhood in Europe: recent and on-going studies.
    Lemerle J
    IARC Sci Publ; 1985; (60):383-98. PubMed ID: 3905590
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
    Dhaliwal HS; Rohatiner AZ; Gregory W; Richards MA; Johnson PW; Whelan JS; Gallagher CJ; Matthews J; Ganesan TS; Barnett MJ
    Br J Cancer; 1993 Oct; 68(4):767-74. PubMed ID: 8398705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
    Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of advanced non-Hodgkin's lymphoma with adriamycin, vincristine, ifosfamide and prednisolone (AVIP): a preliminary report.
    Ohnoshi T; Oka A; Hayashi K; Ueoka H; Sato M; Nishihara R; Yasuoka M; Sando Y; Tanaka T; Kimura I
    Acta Med Okayama; 1982 Feb; 36(1):67-72. PubMed ID: 7064735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlymphoblastic lymphoma in children--histology and stage-related response to therapy: a Pediatric Oncology Group study.
    Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
    J Clin Oncol; 1991 Jul; 9(7):1189-95. PubMed ID: 2045859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma.
    Murphy SB; Hustu HO
    Cancer; 1980 Feb; 45(4):630-7. PubMed ID: 6986967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary study of vincristine, methotrexate, and prednisolone (VM*P) combination chemotherapy for advanced adult non-Hodgkin's lymphoma].
    Takenaka T; Shimoyama M; Minato K; Kitahara T; Konda C
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1814-20. PubMed ID: 7184375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
    Cabanillas F; Burgess MA; Bodey GP; Freireich EJ
    Am J Med; 1983 Mar; 74(3):382-8. PubMed ID: 6187213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End results of treating children with localized non-Hodgkin's lymphomas with a combined modality approach of lessened intensity.
    Murphy SB; Hustu HO; Rivera G; Berard CW
    J Clin Oncol; 1983 May; 1(5):326-30. PubMed ID: 6668503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.